期刊文献+

肠道病毒71型灭活疫苗的免疫原性和保护性效果评价研究 被引量:9

Immunogenicity and protective efficacy of the inactivated EV71 vaccine
原文传递
导出
摘要 目的评价研制的肠道病毒71型(EV71)灭活疫苗的免疫原性和保护性效果。方法 EV71FY7VP5/AH/CHN/2008株感染Vero细胞后,收获病毒培养液,经灭活、浓缩和纯化后制备EV71灭活疫苗,并通过高效液相色谱法(HPLC)进行纯度分析、Western blot进行特异性鉴定。采用不同剂量疫苗免疫食蟹猴,间隔1周采集血清,连续采集9周,采用微量细胞病变抑制法对血清中和抗体进行检测。疫苗免疫动物血清通过腹腔注射至乳鼠后,对乳鼠进行病毒攻击,计算乳鼠生存率及半数动物保护性抗体水平。结果 HPLC分析结果提示,制备的纯化EV71灭活疫苗纯度可达96.6%;Western blot检测结果显示,其可与EV71特异性多抗结合。不同剂量的EV71灭活疫苗免疫食蟹猴,可诱导产生较高水平的EV71特异性中和抗体,中和抗体水平于第2剂接种后1周达到高峰,随后中和抗体维持在一定的水平,中和抗体水平与疫苗剂量存在明显的量效关系;采集小鼠免疫血清,测定中和抗体效价为1∶512,将其进行4、16、64、256倍系列稀释,经腹腔注射乳鼠后,进行病毒攻击,连续观察14d,乳鼠生存率分别为100.0%、100.0%、50.0%、28.6%;对照组乳鼠于病毒攻击后5~7d全部死亡。采用寇氏法计算,平均半数动物保护中和抗体效价为1∶11。结论制备的EV71灭活疫苗可诱导产生高水平的中和抗体,并可保护乳鼠免受EV71感染。 Objective To evaluate the immunogenicity and protective efficacy of the purified inactivated enterovirus 71(EV71)vaccine.Methods The inactivated EV71 vaccine was developed using EV71 strain FY7VP5/AH/CHN/2008 as the virus seed that was grown in Vero cells.The cell culture medium containing viruses was filtered,concentrated by ultrafiltration,further purified by chromatography,inactivated by formaldehyde and adsorbed on Al(OH)3 adjuvant.The purified EV71 vaccine was analyzed using electron microscope,HPLC and Western blotting.The monkeys(cynomolgus macaca fascicularis) were subcutaneously immunized with different dosages of the purified vaccine with Al(OH)3 adjuvant as the control.Monkey blood samples were collected for the measurement of neutralizing antibodies using cytopathic effect inhibition assay.The suckling mice were immunized intraperitoneally(i.p.)with diluted antiserum from immunized mice and then chal-lenged with a dose of 20LD50 virus;the survival rates of the post-challenged newborn mice were observed for 14days and the 50% animal protective antibody level was evaluated.Results The purity of EV71vaccine was 96.6% by HPLC and the purified vaccine reacted efficiently with anti-EV71polyclonal antibody.The vaccine induced high levels of dose-dependent neutralizing antibodies in monkeys with the peak at 1week post-vaccination of the second dose and then maintained at a certain level.At the challenge dose of 20LD 50 virus,no survival in control group at 5-7days post-challenge;while at day 14post-challenge,the survival rates were 100.0%,100.0%,50.0%,and 28.6%in mice immunized with diluted antiserum of neutralization antibody titers at 1∶128,1∶32,1∶8,1∶2,respectively.The average animal protective neutralizing antibody titer was 1∶11.Conclusions The purified inactivated EV71vaccine could induce high levels of neutralizing antibody and provided an effective protection against lethal infection of EV71in the suckling mice.
出处 《中国病毒病杂志》 CAS 2012年第6期415-418,共4页 Chinese Journal of Viral Diseases
基金 国家"十二五"艾滋病和病毒性肝炎等重大传染病防治科技重大专项(2012ZX09101319)
关键词 手足口病 肠道病毒71型 灭活疫苗 免疫原性 保护效果 Hand-foot-mouth disease Enterovirus type 71 Inactivated vaccine Immunogenicity Protective efficacy
  • 相关文献

参考文献10

  • 1Huang HI, Weng KF, Shih SR. Viral and host factors that contribute to pathogenicity of entervirus 71 [J]. Future Mi- crobiol, 2012, 7 (4): 467-479.
  • 2Tseng FC, Huang HC, Chi CY, etal. Epidemiological survey of enterovirus infections occurring in Taiwan between 2000 and 2005: analysis of sentinel physician surveillance data[J]. J MedVirol, 2007, 79 (12): 1850-1860.
  • 3Foo DG, Alonso S, Phoon MC, etal. Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides[J]. Virus Res, 2007, 125 (1): 61-68.
  • 4Foo DG, Alonso S, Chow VT, et al. Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide [J]. Microbes Infect, 2007, 9 (11): 1299-1306.
  • 5Finney DJ. Graphical estimation of relative potency from quantal responses [J]. J Pharmacol Exp Ther, 1952, 104 (4) : 440-444.
  • 6Qiu J. Enterovirus 71 infection:a new threat to global public health?[J]. Lancet Neurol, 2008, 7 (10): 868-869.
  • 7Yu CK, Chen CC, Chen CL, et al . Neutralizing antibody provided protection against enterovirus type 71 lethal chal lengein neonatal mice [J]. J Biomed Sci, 2000, 7 (6): 523-528.
  • 8Wu CN, Lin YC, Fann C, et al. Protection against lethal enterovirus 71 infection in newborn mice by passive immnniL zation with subunit VP1 vaccines and inactivated virus [J]. Vaccine, 2001, 20 (5/6): 895-904.
  • 9McKinney RE, Katz SL, Wilfert CM. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients [J]. RevInfectDis, 1987, 9 (2): 334-356.
  • 10Abzug MJ, Keyserling HL, Lee ML, et al. Neonatal enterovirus infection: virology, serology, and effects of intra-venous immune globulin [J]. Clin Infect Dis, 1995, 20 (5): 1201-1206.

同被引文献82

引证文献9

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部